Found: 9
Select item for more details and to access through your institution.
Modeling the Future Economic Impact of Biosimilars' Entry into the US Market.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
The Economics of Biosimilars.
- Published in:
- American Health & Drug Benefits, 2013, v. 6, n. 8, p. 469
- By:
- Publication type:
- Article
Although five products have reached the market, the debate about biosimilars continues in the United States (U.S.) with an evolving approval process. Interchangeability of biosimilars is not yet solidified nor is the process of how this will happen. A large number of additional biosimilars are likely to hit the market in the next few years.
- Published in:
- Journal of Managed Care Medicine, 2017, v. 20, n. 4, p. 47
- By:
- Publication type:
- Article
Factors Associated with Unintended Pregnancy, Contraceptive Risk-Taking, and Interest in Pharmacist-Provided Birth Control.
- Published in:
- Journal of Contemporary Pharmacy Practice, 2019, v. 66, n. 2, p. 17, doi. 10.37901/jcphp18-00013
- By:
- Publication type:
- Article
Outpatient cancer drug costs.
- Published in:
- Cancer (0008543X), 2002, v. 94, n. 4, p. 1142, doi. 10.1002/cncr.10347
- By:
- Publication type:
- Article
A Managed Care Approach to Outpatient Substance Abuse Treatment.
- Published in:
- Benefits Quarterly, 1990, v. 6, n. 1, p. 30
- By:
- Publication type:
- Article
Disparities in Medical Care Among Commercially Insured Patients With Newly Diagnosed Breast Cancer.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 1, p. 193, doi. 10.1002/cncr.24691
- By:
- Publication type:
- Article
Data-Driven Benefit Design for Chronic Diseases.
- Published in:
- 2009
- By:
- Publication type:
- Opinion
The Working Patient with Cancer: Implications for Payers and Employers.
- Published in:
- American Health & Drug Benefits, 2009, v. 2, n. 4, p. 168
- By:
- Publication type:
- Article